• Tenured Faculty member at the Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, at the University of British Columbia.
  • Authorized by Health Canada to possess psilocybin as the Principal Investigator for the NeonMind Preclinical Trial. 
  • Extensive experience working with controlled substances as part of his research. 
  • His doctoral and post-doctoral research involved a significant body of work using controlled substances.
  • Maintains research programs based on a multidisciplinary and translational approach  in both clinical and related preclinical research related to mental health and addictions.